Molecular Engineering and Sciences Institute, University of Washington, Seattle, Washington 98195, United States.
Department of Bioengineering, University of Washington, Seattle, Washington 98195, United States.
ACS Biomater Sci Eng. 2023 Aug 14;9(8):5062-5071. doi: 10.1021/acsbiomaterials.3c00651. Epub 2023 Jul 19.
The manufacturing process of chimeric antigen receptor T cell therapies includes isolation systems that provide pure T cells. Current magnetic-activated cell sorting and immunoaffinity chromatography methods produce desired cells with high purity and yield but require expensive equipment and reagents and involve time-consuming incubation steps. Here, we demonstrate that aptamers can be employed in a continuous-flow resin platform for both depletion of monocytes and selection of CD8 T cells from peripheral blood mononuclear cells at low cost with high purity and throughput. Aptamer-mediated cell selection could potentially enable fully synthetic, traceless isolations of leukocyte subsets from a single isolation system.
嵌合抗原受体 T 细胞疗法的制造过程包括提供纯 T 细胞的分离系统。目前的磁激活细胞分选和免疫亲和色谱法可以高纯度和高产量地产生所需的细胞,但需要昂贵的设备和试剂,并涉及耗时的孵育步骤。在这里,我们证明了适体可以在连续流树脂平台上以低成本、高纯度和高通量的方式用于耗尽单核细胞和从外周血单核细胞中选择 CD8 T 细胞。适体介导的细胞选择有可能使白细胞亚群从单个分离系统中进行完全合成、无痕迹的分离。